NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

流感疫苗市場規模調查:按年齡組,疫苗類型,管理途徑,分銷渠道2025年全球預測-COVID-19的累積影響

Influenza Vaccine Market Research Report by Vaccine Type, by Age Group, by Administration Route, by Distribution Channel, by Region - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 995371
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
流感疫苗市場規模調查:按年齡組,疫苗類型,管理途徑,分銷渠道2025年全球預測-COVID-19的累積影響 Influenza Vaccine Market Research Report by Vaccine Type, by Age Group, by Administration Route, by Distribution Channel, by Region - Global Forecast to 2025 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 190 Pages
簡介

全球流感疫苗市場預計將從2020年的5,952.68百萬美元增長到2025年底的7,821.79百萬美元。

預計COVID-19將在預測期內對行業增長產生長期影響,因為這是無與倫比的全球公共衛生突發事件,幾乎影響了每個行業。我們正在進行的研究擴大了研究框架,以確保它包括潛在的COVID-19問題和潛在的未來路徑。該調查提供了對COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場勢力動態以及政府的主要干預措施的變化。更新後的調查提供了見解,分析,估計和預測,其中考慮了COVID-19對市場的影響。

在本報告中,我們對流感疫苗市場進行了調查,分析了市場概況,市場增長因素和抑制因素,並根據年齡組,疫苗類型,管理途徑,分銷渠道和地區來改變市場規模,從而提供了全面的信息。諸如預測,COVID-19的累積影響,競爭狀況,主要公司的概況,市場機會等信息。

目錄

第1章簡介

  • 調查目的
  • 市場細分和覆蓋範圍
  • 調查目標年度
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 已發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:創建調查計劃
    • 執行:進行調查
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 市場前景
  • 年齡段展望
  • 管理路線展望
  • 疫苗類型展望
  • 分銷渠道前景
  • 區域展望
  • 競爭對手展望

第4章市場概述

  • COVID-19的累積效果

第5章市場洞察

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
    • 挑戰
  • 波特五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭

第6章按年齡段劃分的全球流感疫苗市場

  • 青少年疫苗接種
  • 成人疫苗接種
  • 嬰兒疫苗接種

第7章按疫苗類型劃分的全球流感疫苗市場

  • 不活化
  • 弱毒生
  • 重組

第8章按管理路線劃分的全球流感疫苗市場

  • 肌肉內
  • 鼻腔中

第9章通過分銷渠道的全球流感疫苗市場

  • 醫院與診所
  • 診所
  • 零售藥房
  • 急診科

第10章美洲流感疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區的流感疫苗市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第12章歐洲,中東和非洲的流感疫苗市場

  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第13章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 競爭情況
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎賞,表彰,擴張

第14章企業可用性概況

  • Abbott Biologicals B.V.
  • AstraZeneca
  • BioDiem
  • BiondVax Pharmaceuticals Ltd.
  • Daiichi-Sankyo
  • Emergent BioSolutions
  • Fluart Innovative Vaccines Kft.
  • GAMMA VACCINES PTY LTD.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Mylan N.V.
  • Pfizer Inc.
  • Sanofi S.A.
  • Seqirus GmbH
  • Serum Institute of India Private Limited

第15章附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-032A67D913F0

The Global Influenza Vaccine Market size was estimated at USD 6,178.90 Million in 2020 and expected to reach USD 6,705.34 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.71% to reach USD 9,382.04 Million by 2025.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2025 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Influenza Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Vaccine Type, the Influenza Vaccine Market was studied across Inactivated, Live Attenuated, and Recombinant.

Based on Age Group, the Influenza Vaccine Market was studied across Adolescent Vaccination, Adult Vaccination, and Infant Vaccination.

Based on Administration Route, the Influenza Vaccine Market was studied across Intramuscular, Intranasal, and Oral.

Based on Distribution Channel, the Influenza Vaccine Market was studied across Government Medical Office, Hospital & Clinic, Retail Pharmacy, and Urgent Care Unit.

Based on Geography, the Influenza Vaccine Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Influenza Vaccine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Influenza Vaccine Market, including Abbott Laboratories, AstraZeneca PLC, Bayer AG, BioDiem, BiondVax Pharmaceuticals Ltd., Bristol-Myers Squibb Company, CanSino Biologics Inc., Daiichi Sankyo Company, Limited, Emergent BioSolutions Inc., Eurocept Group, Fluart Innovative Vaccines Kft., Gamma Vaccines Pty Ltd, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Seqirus GmbH, Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., and Swedish Orphan Biovitrum AB.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Influenza Vaccine Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Influenza Vaccine Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Influenza Vaccine Market?
  • 4. What is the competitive strategic window for opportunities in the Global Influenza Vaccine Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Influenza Vaccine Market?
  • 6. What is the market share of the leading vendors in the Global Influenza Vaccine Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Influenza Vaccine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Age Group Outlook
  • 3.4. Vaccine Type Outlook
  • 3.5. Administration Route Outlook
  • 3.6. Distribution Channel Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Respiratory Disorders
      • 5.1.1.2. Immunization as a Major Public Health Measures for the Prevention of Influenza Virus Infection
      • 5.1.1.3. Clinical Trials and Vaccine Developments in Pipeline for Seasonal Influenzas
      • 5.1.1.4. Government Initiatives Supporting Respiratory Health
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of Inadequate Delivery Infrastructure & Limited Awareness
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing R&D Expenditure by Leading Market Players
      • 5.1.3.2. Increasing Vaccine Availability through Distribution and Development Collaborations
      • 5.1.3.3. Several Vaccine Candidates under Development against Animal Influenza A Virus
    • 5.1.4. Challenges
      • 5.1.4.1. Customers Trust and Confidence in Respiratory Disease Vaccination
      • 5.1.4.2. Vaccine Research and Development are getting Challenged by the Constant Variations in Strains
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Influenza Vaccine Market, by Vaccine Type

  • 6.1. Introduction
  • 6.2. Inactivated
  • 6.3. Live Attenuated
  • 6.4. Recombinant

7. Influenza Vaccine Market, by Age Group

  • 7.1. Introduction
  • 7.2. Adolescent Vaccination
  • 7.3. Adult Vaccination
  • 7.4. Infant Vaccination

8. Influenza Vaccine Market, by Administration Route

  • 8.1. Introduction
  • 8.2. Intramuscular
  • 8.3. Intranasal
  • 8.4. Oral

9. Influenza Vaccine Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Government Medical Office
  • 9.3. Hospital & Clinic
  • 9.4. Retail Pharmacy
  • 9.5. Urgent Care Unit

10. Americas Influenza Vaccine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Influenza Vaccine Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa Influenza Vaccine Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Competitive Scenario
    • 13.4.1. Merger & Acquisition
    • 13.4.2. Agreement, Collaboration, & Partnership
    • 13.4.3. New Product Launch & Enhancement
    • 13.4.4. Investment & Funding
    • 13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Abbott Laboratories
  • 14.2. AstraZeneca PLC
  • 14.3. Bayer AG
  • 14.4. BioDiem
  • 14.5. BiondVax Pharmaceuticals Ltd.
  • 14.6. Bristol-Myers Squibb Company
  • 14.7. CanSino Biologics Inc.
  • 14.8. Daiichi Sankyo Company, Limited
  • 14.9. Emergent BioSolutions Inc.
  • 14.10. Eurocept Group
  • 14.11. Fluart Innovative Vaccines Kft.
  • 14.12. Gamma Vaccines Pty Ltd
  • 14.13. GlaxoSmithKline PLC
  • 14.14. Johnson & Johnson
  • 14.15. Merck & Co., Inc.
  • 14.16. Pfizer Inc.
  • 14.17. Sanofi S.A.
  • 14.18. Seqirus GmbH
  • 14.19. Serum Institute of India Pvt. Ltd.
  • 14.20. Sinovac Biotech Ltd.
  • 14.21. Swedish Orphan Biovitrum AB

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL INFLUENZA VACCINE MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 2. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL INFLUENZA VACCINE MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL INFLUENZA VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2020 VS 2025 (%)
  • FIGURE 10. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2020 VS 2025 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025
  • FIGURE 12. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INACTIVATED, 2018-2025 (USD MILLION)
  • FIGURE 13. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INACTIVATED, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 14. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY LIVE ATTENUATED, 2018-2025 (USD MILLION)
  • FIGURE 15. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 16. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2025 (USD MILLION)
  • FIGURE 17. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RECOMBINANT, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2020 VS 2025 (%)
  • FIGURE 19. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025
  • FIGURE 21. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, 2018-2025 (USD MILLION)
  • FIGURE 22. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 23. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADULT VACCINATION, 2018-2025 (USD MILLION)
  • FIGURE 24. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADULT VACCINATION, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 25. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INFANT VACCINATION, 2018-2025 (USD MILLION)
  • FIGURE 26. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INFANT VACCINATION, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 27. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2020 VS 2025 (%)
  • FIGURE 28. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2020 VS 2025 (USD MILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025
  • FIGURE 30. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRAMUSCULAR, 2018-2025 (USD MILLION)
  • FIGURE 31. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 32. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRANASAL, 2018-2025 (USD MILLION)
  • FIGURE 33. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRANASAL, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 34. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ORAL, 2018-2025 (USD MILLION)
  • FIGURE 35. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 36. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (%)
  • FIGURE 37. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (USD MILLION)
  • FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
  • FIGURE 39. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GOVERNMENT MEDICAL OFFICE, 2018-2025 (USD MILLION)
  • FIGURE 40. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GOVERNMENT MEDICAL OFFICE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 41. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITAL & CLINIC, 2018-2025 (USD MILLION)
  • FIGURE 42. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITAL & CLINIC, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 43. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2025 (USD MILLION)
  • FIGURE 44. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 45. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY URGENT CARE UNIT, 2018-2025 (USD MILLION)
  • FIGURE 46. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY URGENT CARE UNIT, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 47. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 48. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 50. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 52. CANADA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. MEXICO INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 56. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 58. CHINA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 59. INDIA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 60. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 61. JAPAN INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 62. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 63. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 64. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 65. THAILAND INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 66. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 67. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 68. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 69. FRANCE INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 70. GERMANY INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 71. ITALY INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 72. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 73. QATAR INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 74. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 75. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 76. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 77. SPAIN INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 78. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 79. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 80. GLOBAL INFLUENZA VACCINE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 81. GLOBAL INFLUENZA VACCINE MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 82. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INFLUENZA VACCINE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL INFLUENZA VACCINE MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INACTIVATED, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RECOMBINANT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADULT VACCINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INFANT VACCINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRANASAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GOVERNMENT MEDICAL OFFICE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITAL & CLINIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY URGENT CARE UNIT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. CANADA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. CANADA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. CANADA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. CANADA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. MEXICO INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. MEXICO INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. MEXICO INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. MEXICO INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. CHINA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. CHINA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. CHINA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. CHINA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. INDIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. INDIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. INDIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. INDIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. JAPAN INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. JAPAN INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. JAPAN INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. JAPAN INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. THAILAND INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. THAILAND INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. THAILAND INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. THAILAND INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. FRANCE INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. FRANCE INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. FRANCE INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. FRANCE INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. GERMANY INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. GERMANY INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. GERMANY INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. GERMANY INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. ITALY INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. ITALY INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. ITALY INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. ITALY INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. QATAR INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. QATAR INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. QATAR INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. QATAR INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. SPAIN INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. SPAIN INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. SPAIN INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. SPAIN INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 126. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 127. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 128. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 129. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 130. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 131. GLOBAL INFLUENZA VACCINE MARKET: SCORES
  • TABLE 132. GLOBAL INFLUENZA VACCINE MARKET: BUSINESS STRATEGY
  • TABLE 133. GLOBAL INFLUENZA VACCINE MARKET: PRODUCT SATISFACTION
  • TABLE 134. GLOBAL INFLUENZA VACCINE MARKET: RANKING
  • TABLE 135. GLOBAL INFLUENZA VACCINE MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 136. GLOBAL INFLUENZA VACCINE MARKET: MERGER & ACQUISITION
  • TABLE 137. GLOBAL INFLUENZA VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 138. GLOBAL INFLUENZA VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 139. GLOBAL INFLUENZA VACCINE MARKET: INVESTMENT & FUNDING
  • TABLE 140. GLOBAL INFLUENZA VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 141. GLOBAL INFLUENZA VACCINE MARKET: LICENSE & PRICING
  • TABLE 142. GLOBAL INFLUENZA VACCINE MARKET: CONTACT DETAILS